Effects of Tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-masked placebo-controlled phase 3 trials with safety extension data
Injectable evidence is mostly preclinical with strong mechanism data, plus community use
In July 2026, the Pharmacy Compounding Advisory Committee considered Epitalon-related bulk drug substances for possible inclusion on the 503A Bulks List
BPC-157 Mechanism of Action in Research Models BPC-157 appears to act through multiple biological pathways in preclinical studies
Our Process Step 2 Get Your Kit Once approved, your personalized peptide kit is shipped directly to your door with everything you need including detailed instructions and supplies unless your specific peptide requires in-spa administration, in which case youll receive instructions to schedule your in-clinic appointments
Sobanski et al., 2008)